Seminars in Hematology
Volume 47, Issue 1 , Pages 70-78 , January 2010

Transplant Outcomes in Leukodystrophies

  • Paul J. Orchard

      Affiliations

    • Corresponding Author InformationAddress correspondence to Paul J. Orchard, MD, Department of Pediatrics, Division of Hematopoietic Stem Cell Transplantation, University of Minnesota, 420 Delaware St SE, Mayo Mail Code 366, Minneapolis, MN 55455
    • ,
  • Jakub Tolar

References 

  1. Berger J, Moser HW, Forss-Petter S. Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol. 2001;14:305–312
  2. Goldman SA, Schanz S, Windrem MS. Stem cell-based strategies for treating pediatric disorders of myelin. Hum Mol Genet. 2008;17:R76–R83
  3. Aicardi J. The inherited leukodystrophies: a clinical overview. J Inherit Metab Dis. 1993;16:733–743
  4. Porter MT, Fluharty AL, Kihara H. Correction of abnormal cerebroside sulfate metabolism in cultured metachromatic leukodystrophy fibroblasts. Science. 1971;172:1263–1265
  5. Fratantoni JC, Hall CW, Neufeld EF. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science. 1968;162:570–572
  6. Scaravilli F, Jacobs JM. Improved myelination in nerve grafts from the leucodystrophic twitcher into trembler mice: evidence for enzyme replacement. Brain Res. 1982;237:163–172
  7. Hobbs JR. Bone marrow transplantation for inborn errors. Lancet. 1981;2:735–739
  8. Suzuki K, Chen G. Metachromatic leucodystrophy: isolation and chemical analysis of metachromatic granules. Science. 1966;151:1231–1233
  9. Gieselmann V, Polten A, Kreysing J, von Figura K. Molecular genetics of metachromatic leukodystrophy. J Inherit Metab Dis. 1994;17:500–509
  10. Eng B, Nakamura LN, O'Reilly N, Schokman N, Nowaczyk MM, Krivit W, et al. Identification of nine novel arylsulfatase a (ARSA) gene mutations in patients with metachromatic leukodystrophy (metachromatic leukodystrophy). Hum Mutat. 2003;22:418–419
  11. Heinisch U, Zlotogora J, Kafert S, Gieselmann V. Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area. Am J Hum Genet. 1995;56:51–57
  12. Zlotogora J, Bach G, Bosenberg C, Barak Y, von Figura K, Gieselmann V. Molecular basis of late infantile metachromatic leukodystrophy in the Habbanite Jews. Hum Mutat. 1995;5:137–143
  13. Gieselmann V. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. Acta Paediatr Suppl. 2008;97:15–21
  14. Fluharty AL, Meek WE, Kihara H. Pseudo arylsulfatase A deficiency: evidence for a structurally altered enzyme. Biochem Biophys Res Commun. 1983;112:191–197
  15. Sedel F, Tourbah A, Fontaine B, Lubetzki C, Baumann N, Saudubray JM, et al. Leukoencephalopathies associated with inborn errors of metabolism in adults. J Inherit Metab Dis. 2008;31:295–307
  16. Herz B, Bach G. Arylsulfatase A in pseudodeficiency. Hum Genet. 1984;66:147–150
  17. Gieselmann V, Zlotogora J, Harris A, Wenger DA, Morris CP. Molecular genetics of metachromatic leukodystrophy. Human Mutat. 1994;4:233–242
  18. Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW. The metabolic and molecular bases of inherited disease. In: 8th ed.. New York: McGraw-Hill Professional; 2001;p. 3695–3724
  19. Biffi A, Lucchini G, Rovelli A, Sessa M. Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant. 2008;42(Suppl 2):S2–S6
  20. Krivit W, Shapiro E, Kennedy W, Lipton M, Lockman L, Smith S, et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N Engl J Med. 1990;322:28–32
  21. Orchard PJ, Blazar BR, Wagner J, Charnas L, Krivit W, Tolar J. Hematopoietic cell therapy for metabolic disease. J Pediatr. 2007;151:340–346
  22. Peters C, Kriviit W. Metabolic diseases. In:  Ball E editors. Hemapoietic stem cell therapy. Philadelphia: Churchill Livingstone; 2000;p. 169–183
  23. Peters C, Steward CG. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant. 2003;31:229–239
  24. Peters C. Hematopoietic stem cell transplantation for storage diseases. In:  Appelbaum FR,  Forman SJ,  Negrin RS editor. Thomas' hematopoietic cell transplantation: stem cell transplantation. 4th ed.. Oxford, UK: Wiley; 2009;p. 1136–1162
  25. Gorg M, Wilck W, Granitzny B, Suerken A, Lukacs Z, Ding X, et al. Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up. J Child Neurol. 2007;22:1139–1142
  26. Solders G, Celsing G, Hagenfeldt L, Ljungman P, Isberg B, Ringden O. Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy. Bone Marrow Transplant. 1998;22:1119–1122
  27. Pierson TM, Bonnemann CG, Finkel RS, Bunin N, Tennekoon GI. Umbilical cord blood transplantation for juvenile metachromatic leukodystrophy. Ann Neurol. 2008;64:583–587
  28. Krabbe K. A new familial, infantile form of diffuse brain sclerosis. Brain. 1916;39:74–114
  29. Suzuki K, Suzuki Y. Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci U S A. 1970;66:302–309
  30. Zlotogora J, Chakraborty S, Knowlton RG, Wenger DA. Krabbe disease locus mapped to chromosome 14 by genetic linkage. Am J Hum Genet. 1990;47:37–44
  31. Chen YQ, Rafi MA, de Gala G, Wenger DA. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum Mol Genet. 1993;2:1841–1845
  32. Tatsumi N, Inui K, Sakai N, Fukushima H, Nishimoto J, Yanagihara I, et al. Molecular defects in Krabbe disease. Hum Mol Genet. 1995;4:1865–1868
  33. Igisu H, Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science. 1984;224:753–755
  34. Suzuki K. Twenty five years of the “psychosine hypothesis”: a personal perspective of its history and present status. Neurochem Res. 1998;23:251–259
  35. White AB, Givogri MI, Lopez-Rosas A, Cao H, van Breemen R, Thinakaran G, et al. Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture. J Neurosci. 2009;29:6068–6077
  36. Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW. The metabolic and molecular bases of inherited disease. In: New York: McGraw-Hill Professional; 2001;p. 3669–3694
  37. Krivit W, Shapiro EG, Peters C, Wagner JE, Cornu G, Kurtzberg J, et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med. 1998;338:1119–1126
  38. Escolar ML, Poe MD, Martin HR, Kurtzberg J. A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation. Pediatrics. 2006;118:e879–e889
  39. Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352:2069–2081
  40. Duffner PK, Caggana M, Orsini JJ, Wenger DA, Patterson MC, Crosley CJ, et al. Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol. 2009;40:245–252
  41. Meikle PJ, Grasby DJ, Dean CJ, Lang DL, Bockmann M, Whittle AM, et al. Newborn screening for lysosomal storage disorders. Mol Genet Metab. 2006;88:307–314
  42. Duffner PK, Caviness VS, Erbe RW, Patterson MC, Schultz KR, Wenger DA, et al. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York. Genet Med. 2009;11:450–454
  43. Kagitani-Shimono K, Mohri I, Yagi T, Taniike M, Suzuki K. Peripheral neuropathy in the twitcher mouse: accumulation of extracellular matrix in the endoneurium and aberrant expression of ion channels. Acta Neuropathol. 2008;115:577–587
  44. Kondo A, Hoogerbrugge PM, Suzuki K, Poorthuis BJ, Van Bekkum DW, Suzuki K. Pathology of the peripheral nerve in the twitcher mouse following bone marrow transplantation. Brain Res. 1988;460:178–183
  45. Luzi P, Rafi MA, Zaka M, Rao HZ, Curtis M, Vanier MT, et al. Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantation. Mol Genet Metab. 2005;86:150–159
  46. Lim ZY, Ho AY, Abrahams S, Fensom A, Aldouri M, Pagliuca A, et al. Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease. Bone Marrow Transplant. 2008;41:831–832
  47. Cartier N, Aubourg P. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. Curr Opin Mol Ther. 2008;10:471–478
  48. Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976;26:851–860
  49. Moser AB, Kreiter N, Bezman L, Lu S, Raymond GV, Naidu S, et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol. 1999;45:100–110
  50. Moser HW. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy. J Neuropathol Exp Neurol. 1995;54:740–745
  51. Mahmood A, Dubey P, Moser HW, Moser A. X-linked adrenoleukodystrophy: Therapeutic approaches to distinct phenotypes. Pediatr Transplant. 2005;9(Suppl):55–62
  52. Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA. 2005;294:3131–3134
  53. Powers JM, Liu Y, Moser AB, Moser HW. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol. 1992;51:630–643
  54. McGuinness MC, Griffin DE, Raymond GV, Washington CA, Moser HW, Smith KD. Tumor necrosis factor-alpha and X-linked adrenoleukodystrophy. J Neuroimmunol. 1995;61:161–169
  55. McGuinness MC, Smith KD. Cerebral inflammation in X-linked adrenoleukodystrophy. Arch Immunol Ther Exp. 1999;47:281–287
  56. Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, Singh I. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-adrenoleukodystrophy: implications for potential therapies. Neurobiol Dis. 2003;14:425–439
  57. Moser HW, Powers JM, Smith KD. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil. Brain Pathol. 1995;5:259–266
  58. Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol. 2005;64:1067–1079
  59. Aubourg P, Blanche S, Jambaque I, Rocchiccioli F, Kalifa G, Naud-Saudreau C, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med. 1990;322:1860–1866
  60. Moser HW, Tutschka PJ, Brown FR, Moser AE, Yeager AM, Singh I, et al. Bone marrow transplant in adrenoleukodystrophy. Neurology. 1984;34:1410–1417
  61. Shapiro E, Krivit W, Lockman L, Jambaque I, Peters C, Cowan M, et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet. 2000;356:713–718
  62. Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, et al. A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1997;94:9366–9371
  63. Yamada T, Shinnoh N, Kondo A, Uchiyama A, Shimozawa N, Kira J, et al. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice. Cell Biochem Biophys. 2000;32:239–246
  64. Eichler F, Van Haren K. Immune response in leukodystrophies. Pediatric Neurology. 2007;37:235–244
  65. Yamada T, Ohyagi Y, Shinnoh N, Kikuchi H, Osoegawa M, Ochi H, et al. Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-adrenoleukodystrophy mouse model. J Neurol Sci. 2004;218:91–97
  66. Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, Moser AB, et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?. Ann Neurol. 2008;63:729–742
  67. Flavigny E, Sanhaj A, Aubourg P, Cartier N. Retroviral-mediated adrenoleukodystrophy-related gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implications for therapy. FEBS Lett. 1999;448:261–264
  68. Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004;104:881–888
  69. Boelens JJ. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis. 2006;29:413–420
  70. Tolar J, Orchard PJ, Bjoraker KJ, Ziegler RS, Shapiro EG, Charnas L. N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant. 2007;39:211–215
  71. Loes DJ, Stillman AE, Hite S, Shapiro E, Lockman L, Latchaw RE, et al. Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations. AJNR Am J Neuroradiol. 1994;15:1767–1771
  72. Krivit W, Sung JH, Shapiro EG, Lockman LA. Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant. 1995;4:385–392
  73. Kennedy DW, Abkowitz JL. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood. 1997;90:986–993
  74. Priller J, Flugel A, Wehner T, Boentert M, Haas CA, Prinz M, et al. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med. 2001;7:1356–1361
  75. Tanaka R, Komine-Kobayashi M, Mochizuki H, Yamada M, Furuya T, Migita M, et al. Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience. 2003;117:531–539

PII: S0037-1963(09)00137-1

doi: 10.1053/j.seminhematol.2009.10.006

Seminars in Hematology
Volume 47, Issue 1 , Pages 70-78 , January 2010

Article Tools

* Image Usage & Resolution